 | Up a level |
2020
Scheid, C., Basic, E., Sellner, L., Ratsch, B. and Blau, W., I (2020). Changes in the treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from a large German claims database. Oncol. Res. Treat., 43 (SUPPL 4). S. 105 - 107. BASEL: KARGER. ISSN 2296-5262
2018
Andersson, E. I., Puetzer, S., Yadav, B., Dufva, O., Khan, S., He, L., Sellner, L., Schrader, A., Crispatzu, G., Oles, M., Zhang, H., Adnan-Awad, S., Lagstrom, S., Bellanger, D., Mpindi, J. P., Eldfors, S., Pemovska, T., Pietarinen, P., Lauhio, A., Tomska, K., Cuesta-Mateos, C., Faber, E., Koschmieder, S., Bruemmendorf, T. H., Kytola, S., Savolainen, E-R, Siitonen, T., Ellonen, P., Kallioniemi, O., Wennerberg, K., Ding, W., Stern, M-H, Huber, W., Anders, S., Tang, J., Aittokallio, T., Zenz, T., Herling, M. and Mustjoki, S. (2018). Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling. Leukemia, 32 (3). S. 774 - 788. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
2014
Sellner, L., Oles, M., Anders, S., Zapatka, M., Lukas, M., Slabicki, M., Blume, C., Huellein, J., Stolz, T., Muley, C., Sill, M., Oakes, C. C., Dietrich, S., Merkel, O., Jauch, A., Schrader, A., Hensel, M., Rossi, D., Zirlik, K., Herling, M., Nguyen-Khac, F., Seiffert, M., Dreger, P., von Kalle, C., Ho, A. D., Glimm, H., Duerig, J., Ringshausen, I., Huber, W. and Zenz, T. (2014). SYSTEMATIC DRUG SENSITIVITY SCREENING IN LYMPHOID MALIGNANCIES IDENTIFIES VULNERABILITIES OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH HIGH RISK ABERRATIONS. Haematologica, 99. S. 316 - 317. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078